Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 28, 2023; 29(4): 706-730
Published online Jan 28, 2023. doi: 10.3748/wjg.v29.i4.706
Published online Jan 28, 2023. doi: 10.3748/wjg.v29.i4.706
Item | Description |
Schemes | Scheme 1 Gastrointestinal endoscopy for all people without blood tests |
Scheme 2 Both of gastroscopy and colonoscopy when blood tests were positive | |
Scheme 3 Gastroscopy first when blood tests were positive, and then colonoscopy when the result of gastroscopy was negative | |
Scheme 4 Colonoscopy first when blood tests were positive, and then gastroscopy when the result of colonoscopy was negative | |
Scheme 5 Only gastroscopy when blood tests were positive | |
Scheme 6 Only colonoscopy when blood tests were positive | |
Examination prices | CEA, $4.64; CA19-9, $7.25; CA72-4, $7.25 |
Gastroscopy & biopsy, $87.99 | |
Colonoscopy, $57.98; biopsy after colonoscopy, $32.62 |
- Citation: Liu HN, Yao C, Wang XF, Zhang NP, Chen YJ, Pan D, Zhao GP, Shen XZ, Wu H, Liu TT. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers. World J Gastroenterol 2023; 29(4): 706-730
- URL: https://www.wjgnet.com/1007-9327/full/v29/i4/706.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i4.706